Dupilumab in the Treatment of Pediatric Alopecia Areata

PHASE2RecruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

July 11, 2024

Primary Completion Date

May 30, 2028

Study Completion Date

May 30, 2029

Conditions
Alopecia Areata
Interventions
DRUG

Dupilumab

Participants weighing 15 kg \< 30 kg = 300 mg Every 4 Weeks; Participants weighing 30 kg \< 60 kg = 200 mg Every 2 Weeks; Participants weighing ≥ 60 kg = 300 mg Every 2 Weeks;

DRUG

Placebo

Participants weighing 15 kg \< 30 kg Every 4 Weeks; Participants weighing 30 kg \< 60 kg Every 2 Weeks; Participants weighing ≥ 60 kg Every 2 Weeks

Trial Locations (4)

10029

RECRUITING

Icahn School of Medicine at Mount Sinai, New York

60611

RECRUITING

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago

RECRUITING

Northwestern University Feinberg School of Medicine, Chicago

92697

RECRUITING

University of California, Irvine, Irvine

All Listed Sponsors
lead

Icahn School of Medicine at Mount Sinai

OTHER